Sinovac Biotech annual depreciation and amortization
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Sinovac Biotech Depreciation & Amortization Growth & History (SVA)
Sinovac Biotech's depreciation and amortization was $98.8M for fiscal 2025.
View full Sinovac Biotech company overviewSinovac Biotech annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $98.8M | −$12.5M | −11.23% |
| 2024 | 2024-12-31 | $111.3M | −$47.2M | −29.77% |
| 2023 | 2023-12-31 | $158.4M | $5.3M | +3.46% |
| 2022 | 2022-12-31 | $153.1M | $67.9M | +79.65% |
| 2021 | 2021-12-31 | $85.2M | $81.5M | +2143.99% |
| 2020 | 2020-12-31 | $3.8M | −$780,000 | −17.03% |
| 2019 | 2019-12-31 | $4.6M | −$308,000 | −6.30% |
| 2018 | 2018-12-31 | $4.9M | $249,000 | +5.37% |
| 2017 | 2017-12-31 | $4.6M | −$425,000 | −8.39% |
| 2016 | 2016-12-31 | $5.1M | −$1.2M | −19.10% |
| 2015 | 2015-12-31 | $6.3M | −$1.6M | −20.15% |
| 2014 | 2014-12-31 | $7.8M | $2.2M | +38.41% |
| 2013 | 2013-12-31 | $5.7M | $1.2M | +26.18% |
| 2012 | 2012-12-31 | $4.5M | −$338,202 | −7.01% |
| 2011 | 2011-12-31 | $4.8M | $593,510 | +14.02% |
| 2010 | 2010-12-31 | $4.2M | $2.0M | +89.01% |
| 2009 | 2009-12-31 | $2.2M | — | — |
Sinovac Biotech depreciation and amortization trends
Over the last five fiscal years, Sinovac Biotech's depreciation and amortization increased from $3.8M to $98.8M, a change of $95.0M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sinovac Biotech source filings ↗